SCHEMBL822824

SCHEMBL822824

CCCC(S)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11173127 0.83
SCHEMBL6160088 0.79 ADH1B (0.47)
SCHEMBL11575566 0.79 ADH1B (0.47)
SCHEMBL31595891 0.79 ADH1B (0.47)
SCHEMBL10584257 0.79 ADH1B (0.47)
SCHEMBL20214582 0.79 ADH1B (0.47)
SCHEMBL1258586 0.75
SCHEMBL14045047 0.75
SCHEMBL28922725 0.73
Ammonia Solution, Strong SCHEMBL5701904 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968734-B2 Organocatalysts and methods of use in chemical synthesis STC.UNM (US) 2011-06-28 US disclosed
EP-1309739-A1 PROCESS FOR THE PRODUCTION OF 2-HYDROXY-4-METHYLMERCAPTOBUTYRIC ACID Degussa AG (DE) 2003-05-14 EP disclosed
WO-2002016671-A1 PROCESS FOR THE PRODUCTION OF 2-HYDROXY-4-METHYLMERCAPTOBUTYRIC ACID DEGUSSA AG (DE) 2002-02-28 WO disclosed
EP-0307476-A1 BILIRUBIN ANTIGEN, MONOCLONAL ANTIBODY THEREFOR, PROCESS FOR THEIR PREPARATION, AND THEIR USE KUKITA, Takeshi (JP) 1989-03-22 EP disclosed